title: American Chemical Society--234th National Meeting. Therapeutics for neurological indications. 19-23 August 2007, Boston, MA, USA.
authors: Thomson Scientific, 77 Hatton Garden, London, EC1N 8JS, UK. christopher.dalziel@thomson.com
authors: Chris
authors: C
authors: Dalziel
authors: Claire
authors: C
authors: Veryard
mesh_terms: D000818:Animals; D001007:Anxiety / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003371:Cough / Q000188:drug therapy; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D008881:Migraine Disorders / Q000188:drug therapy; D009420:Nervous System / Q000187:drug effects*; D018377:Neurotransmitter Agents / Q000494:pharmacology*
chemical_list: D018377:Neurotransmitter Agents